Elevated levels of NfH in the CSF were associated with a higher risk of developing MS in patients with clinically isolated syndrome (CIS), suggesting that NfH may be a useful biomarker for predicting conversion to MS (Khalil et al., 2013). This evidence concerns the gene NEFH and in situ carcinoma.